Journal of Nanobiotechnology

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Nanobiotechnology is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,190 EUR. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1477-3155
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,190 EUR
Articles in DOAJ
4670
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2003-06-26
  • MEDLINE · 2011-01-01
  • PUBMED · 2003-01-28
Indexing
DOAJ · MEDLINE · PUBMED
APC
3,190 EUR
Declared review time (DOAJ)
16 weeks
Actual review time (measured)
102 days received→accepted — computed from PubMed (n=81)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

4670

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

4982

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

167

i10-index

3249

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2003-06-26
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
LOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2027
Level 1 — approved scholarly channel
Open references deposited at Crossref
85%
ORCID iDs in current deposits
10%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
JN
Source type
journal
NLM unique ID (PubMed)
101152208
Classification4

Subjects (DOAJ)

Technology: Chemical technology: BiotechnologyMedicine: Medicine (General): Medical technology

LCC codes

TP248.13-248.65R855-855.5

Subject areas

  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Advanced Nanomaterials in Catalysis
  • Advanced Nanomaterials in Catalysis
Show all subjects (50)
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Nanoparticles: synthesis and applications
  • Nanoparticles: synthesis and applications
  • Graphene and Nanomaterials Applications
  • Graphene and Nanomaterials Applications
  • Immune cells in cancer
  • Immune cells in cancer
  • Wound Healing and Treatments
  • Wound Healing and Treatments
  • Immunotherapy and Immune Responses
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Immunotherapy and Immune Responses
  • Bone Tissue Engineering Materials
  • Bone Tissue Engineering Materials
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Photodynamic Therapy Research Studies
  • Photodynamic Therapy Research Studies
  • Cancer Research and Treatments
  • Carbon and Quantum Dots Applications
  • Cancer Research and Treatments
  • Carbon and Quantum Dots Applications
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • interferon and immune responses
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • 3D Printing in Biomedical Research
  • Cancer Immunotherapy and Biomarkers
  • interferon and immune responses
  • 3D Printing in Biomedical Research
  • Cancer Immunotherapy and Biomarkers
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Gold and Silver Nanoparticles Synthesis and Applications

Keywords (DOAJ)

  • biotechnology
  • nanoscale sciences
  • nanomaterials
  • nanosensors
  • nanoparticles
  • nanomedicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: